Pregled bibliografske jedinice broj: 1111801
Discriminatory potential of IgG N-glycosylation in chronic graft-versus-disease
Discriminatory potential of IgG N-glycosylation in chronic graft-versus-disease // Bone marrow transplantation. Supplement, Volume: 53.
Lisabon, Portugal, 2018. str. 406-408 (predavanje, međunarodna recenzija, prošireni sažetak, znanstveni)
CROSBI ID: 1111801 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Discriminatory potential of IgG N-glycosylation in
chronic graft-versus-disease
Autori
Prenc, Ema ; Pulanic, Drazen ; Ugrina, Ivo ; Desnica, Lana ; Bakovic, Maja Pucic ; Stambuk, Jerko ; Milosevic, Milan ; Seiwerth, Ranka Serventi ; Durakovic, Nadira ; Peric, Zinaida ; Vrhovac, Radovan ; Nemet, Damir ; Lauc, Gordan ; Pavletic, Steven Z.
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, prošireni sažetak, znanstveni
Izvornik
Bone marrow transplantation. Supplement, Volume: 53.
/ - , 2018, 406-408
Skup
The 44th Annual Meeting of the European Society for Blood and Marrow Transplantation
Mjesto i datum
Lisabon, Portugal, 18.03.2018. - 21.03.2018
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
glycan ; glycosylation ; graft versus host disease ; hematopoietic stem cell transplantation
Sažetak
Background Glycans, complex oligosaccharides, are directly involved in almost every biological process, have a fundamental role in the immune system and are probably involved in nearly every human disease. However, glycosylation has been greatly ignored in the area of allogeneic hematopoietic stem cell transplantation (alloHSCT) and graft versus host disease (GVHD). Both acute and chronic GVHD are multisystemic debilitating immunological disturbances arising after alloHSCT. Scope of Review In this paper we review the glycosylation research already done in the field of alloHSCT and GVHD, and evaluate further potential of glycan analysis in GVHD by looking into resembling inflammatory and autoimmune conditions. Major Conclusions Glycan research could bring significant improvement in alloHSCT procedure with reduction in following complications, such as GVHD. Identifying glycan patterns that induce self-tolerance and the ones that cause the auto- and allo-immune response could lead to innovative and tissue specific immunomodulative therapy instead of the current immunosuppressive treatment, enabling preservation of the graft-versus-tumor effect. Moreover, improved glycan pattern analyses could offer a more complete assessment and greatly needed dynamic biomarkers for GVHD. General Significance This review is written with a goal to encourage glycan research in the field of alloHSCT and GVHD as a perspective tool leading to improved engraftment, discovery of much needed biomarkers for GVHD, enabling an appropriate therapy and improved monitoring of therapeutic response.
Izvorni jezik
Engleski
Znanstvena područja
Biologija
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Prirodoslovno-matematički fakultet, Split,
GENOS d.o.o.
Profili:
Gordan Lauc
(autor)
JERKO ŠTAMBUK
(autor)
Steven Živko Pavletić
(autor)
Ivo Ugrina
(autor)
Dražen Pulanić
(autor)
Milan Milošević
(autor)
Zinaida Perić
(autor)
Damir Nemet
(autor)
Nadira Duraković
(autor)
Radovan Vrhovac
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Conference Proceedings Citation Index - Science (CPCI-S)
- MEDLINE